1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Heterologous Prime/Boost Covid-19 Vaccine Schedules Emerging Data From the COM-COV and COM-Boost Studies"}],["$","meta","1",{"name":"description","content":"COVID-19 Lecture\n\nMatthew Snape, MBBS FRCPCH MD, is an Professor in General Paediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Paediatrics and the NIHR Oxford Biomedical Research Council. He is also a Jenner Investigator and works as a General Paediatrician at the Children’s Hospital Oxford, Oxford University Hospitals NHS Trust. Lecture objectives will be (1) Understanding potential rationale for use of mixed COVID-19 vaccine schedules, (2) Review of the available immunogenicity and safety data, with particular focus on the COMCOV and COV-Boost studies, and (3) Relevance for Variants of Concern and persistence of immunity.

For more information go to https://www.niaid.nih.gov/research/covid-19-sig"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Heterologous Prime/Boost Covid-19 Vaccine Schedules Emerging Data From the COM-COV and COM-Boost Studies"}],["$","meta","4",{"property":"og:description","content":"COVID-19 Lecture\n\nMatthew Snape, MBBS FRCPCH MD, is an Professor in General Paediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Paediatrics and the NIHR Oxford Biomedical Research Council. He is also a Jenner Investigator and works as a General Paediatrician at the Children’s Hospital Oxford, Oxford University Hospitals NHS Trust. Lecture objectives will be (1) Understanding potential rationale for use of mixed COVID-19 vaccine schedules, (2) Review of the available immunogenicity and safety data, with particular focus on the COMCOV and COV-Boost studies, and (3) Relevance for Variants of Concern and persistence of immunity.

For more information go to https://www.niaid.nih.gov/research/covid-19-sig"}],["$","meta","5",{"property":"og:url","content":"https://videocast.nih.gov/watch/c36b02a2-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/ac304934-12ea-491c-82fe-3bf6eda58455.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Heterologous Prime/Boost Covid-19 Vaccine Schedules Emerging Data From the COM-COV and COM-Boost Studies"}],["$","meta","11",{"name":"twitter:description","content":"COVID-19 Lecture\n\nMatthew Snape, MBBS FRCPCH MD, is an Professor in General Paediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Paediatrics and the NIHR Oxford Biomedical Research Council. He is also a Jenner Investigator and works as a General Paediatrician at the Children’s Hospital Oxford, Oxford University Hospitals NHS Trust. Lecture objectives will be (1) Understanding potential rationale for use of mixed COVID-19 vaccine schedules, (2) Review of the available immunogenicity and safety data, with particular focus on the COMCOV and COV-Boost studies, and (3) Relevance for Variants of Concern and persistence of immunity.

For more information go to https://www.niaid.nih.gov/research/covid-19-sig"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}